Skip to main content

Table 1 Basic characteristics of the patients

From: Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes

Age (years)

48.2 ± 10.7

Gender (male/female)

10/10

Body weight (kg)

91.7 ± 22.3

Body mass index (kg/m2)

33.0 ± 4.9

Systolic blood pressure (mmHg)

128.5 ± 11.0

Diastolic blood pressure (mmHg)

74.4 ± 10.4

BUN (mg/dL)

13.0 ± 3.9

Creatinine (mg/dL)

0.63 ± 0.16

HbA1c (%)

9.2 ± 1.4

Medication

 Anti-hypertensive agents (%)

11 (55%)

 Lipid-regulating agents (%)

10 (50%)

 Oral anti-diabetic agents (%)

19 (95%)

 Insulin (%)

10 (50%)

  1. BUN blood urea nitrogen; HbA1c glycosylated hemoglobin